fda glp-1 warning october 2025 GLP-1s in 2026: What Brokers Need to Know FDA Issues Warning Letters to

Full AI Image Prompt: Create a clean regulatory infographic titled GHK-Cu Regulatory Context Map. Show a horizontal map with four labeled blocks: Cosmetic context, Non-injectable compounding review, Injectable safety concern, and Approved drug labeling. Include a small callout that says Product category affects evidence and safety interpretation. Use document-style icons, simple arrows, and a professional clinical design with white background, gray, blue, and copper accents

It helps maintain a strong heart, immune function, and eye and lung health

It is not intended for human or animal consumption, therapeutic use, or any other application

Not effective for individuals with severe deficiencies

Quantitative proteomics BALF from PA infected WT, Thbs1 / , PF4 Cre Thbs1 flox and PF4 WT Thbs1 flox mice were collected at day 1 post-infection and centrifuged at 300 x g for 15 min to separate the pellet from the supernatant